IKK classic hereby announces that it will conclude non-exclusive discount agreements with all interested and suitable pharmaceutical companies in the period from 01.11.2023 to 31.10.2025 for various active ingredients and combinations of active ingredients in accordance with § 130a para. 8 SGB V on the same, non-negotiable conditions. The earliest start date of the contract is 01.11.2023, provided that the signed contract and all necessary evidence, self-declarations and documents are received by IKK classic by 05.10.2023. Thereafter, the following applies: If the documents are received by the 5th of each month in the possible accession period, the 1st of the following month will be the start of the contract. If the documents are received after the 5th of each month in the possible accession period, the 1st of the month after next will be the start of the contract. Joining the agreement is possible at any time during the specified period, but no later than 05.09.2025. For further information, see point VI.3).
Calcipotriol; Creme; ATC-Code: D05AX02Calcipotriol; Creme; ATC-Code: D05AX02
emtricitabine, tenofovir disoproxil and rilpivirine; ATC code: J05AR08emtricitabine, tenofovir disoproxil and rilpivirine; ATC code: J05AR08
Ezetimib und Rosuvastatin; 10 und 40 mg; ATC-Code: C10BA06Ezetimib und Rosuvastatin; 10 und 40 mg; ATC-Code: C10BA06
Granisetron; Pflaster; ATC-Code: A04AA02Granisetron; Pflaster; ATC-Code: A04AA02
ibrutinib; ATC code: L01EL01ibrutinib; ATC code: L01EL01
lamivudine, abacavir and dolutegravir; ATC code: J05AR13lamivudine, abacavir and dolutegravir; ATC code: J05AR13
mercaptopurine ATC code: L01BB02mercaptopurine ATC code: L01BB02
Methylphenidate; Hard capsules with modified release of active ingredients; release rate 30/70; ATC Code: N06BA04Methylphenidate; Hard capsules with modified release of active ingredients; release rate 30/70; ATC Code: N06BA04
Midazolam; Fertigspritzen; ATC-Code: N05CD08Midazolam; Fertigspritzen; ATC-Code: N05CD08
olanzapine; dry matter with solvent; ATC code: N05AH03olanzapine; dry matter with solvent; ATC code: N05AH03
Oxybutynin; Installation; ATC-Code: G04BD04Oxybutynin; Installation; ATC-Code: G04BD04
calcipotriol and betamethasone; cream, foam; ATC code: D05AX52calcipotriol and betamethasone; cream, foam; ATC code: D05AX52
pimecrolimus; ATC code: D11AH02pimecrolimus; ATC code: D11AH02
pyridostigmine; coated tablets; ATC Code: N07AA02pyridostigmine; coated tablets; ATC Code: N07AA02
salbutamol 1.25 mg; solution for a nebulizer; ATC Code: R03AC02salbutamol 1.25 mg; solution for a nebulizer; ATC Code: R03AC02
sofosbuvir, velpatasvir and voxilaprevir; ATC code: J05AP56sofosbuvir, velpatasvir and voxilaprevir; ATC code: J05AP56
cefadroxil; ATC code: J01DB05cefadroxil; ATC code: J01DB05
clobazam; atc code: n05BA09clobazam; atc code: n05BA09
clonazepam; oral drops; ATC code: N03AE01clonazepam; oral drops; ATC code: N03AE01
Dienogest und Estrogen; 2 mg / 1mg; ATC-Code: G03FA15Dienogest und Estrogen; 2 mg / 1mg; ATC-Code: G03FA15
Dolutegravir; ATC-Code: J05AJ03Dolutegravir; ATC-Code: J05AJ03
emtricitabine, tenofovir alafenamide and rilpivirine; ATC code: J05AR19emtricitabine, tenofovir alafenamide and rilpivirine; ATC code: J05AR19
emtricitabine, tenofovir alafenamide, darunavir and cobicistat; ATC code: J05AR22emtricitabine, tenofovir alafenamide, darunavir and cobicistat; ATC code: J05AR22